{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T18:42:43Z","timestamp":1758393763793,"version":"3.44.0"},"reference-count":15,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,27]],"date-time":"2023-01-27T00:00:00Z","timestamp":1674777600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["jidonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.jid.2022.12.023","type":"journal-article","created":{"date-parts":[[2023,1,27]],"date-time":"2023-01-27T22:49:13Z","timestamp":1674859753000},"page":"1601-1604","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["SARS-CoV-2 Vaccination Effectiveness in Rituximab-Treated Patients Affected by Pemphigus Vulgaris"],"prefix":"10.1016","volume":"143","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0735-8331","authenticated-orcid":false,"given":"Claudio","family":"Fenizia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0060-5870","authenticated-orcid":false,"given":"Chiara","family":"Moltrasio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5002-6845","authenticated-orcid":false,"given":"Luisa","family":"Ottobrini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9571-6057","authenticated-orcid":false,"given":"Olga","family":"Utyro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7636-958X","authenticated-orcid":false,"given":"Giovanni","family":"Genovese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4490-6675","authenticated-orcid":false,"given":"Claudia","family":"Vanetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9535-3359","authenticated-orcid":false,"given":"Daria","family":"Trabattoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8160-4169","authenticated-orcid":false,"given":"Angelo V.","family":"Marzano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jid.2022.12.023_bib1","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1038\/s41591-021-01507-2","article-title":"Cellular and humoral immune responses following SARS-CoV-2 mRNA vaccination in patients with multiple sclerosis on anti-CD20 therapy","volume":"27","author":"Apostolidis","year":"2021","journal-title":"Nat Med"},{"key":"10.1016\/j.jid.2022.12.023_bib2","doi-asserted-by":"crossref","first-page":"SI163","DOI":"10.1093\/rheumatology\/keab815","article-title":"Risk factors of impaired humoral response to COVID-19 vaccination in rituximab treated patients","volume":"61","author":"Avouac","year":"2022","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jid.2022.12.023_bib3","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/cei.13495","article-title":"COVID-19 vaccine-readiness for anti-CD20-depleting therapy in autoimmune diseases","volume":"202","author":"Baker","year":"2020","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jid.2022.12.023_bib4","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1038\/s41591-021-01386-7","article-title":"CD8+ T cells contribute to survival in patients with COVID-19 and hematologic cancer","volume":"27","author":"Bange","year":"2021","journal-title":"Nat Med"},{"key":"10.1016\/j.jid.2022.12.023_bib5","doi-asserted-by":"crossref","DOI":"10.1111\/dth.14405","article-title":"Rituximab as the treatment of pemphigus vulgaris in the COVID-19 pandemic era: a narrative review","volume":"34","author":"Beyzaee","year":"2021","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.jid.2022.12.023_bib6","doi-asserted-by":"crossref","DOI":"10.1126\/science.abf4063","article-title":"Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection","volume":"371","author":"Dan","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.jid.2022.12.023_bib7","doi-asserted-by":"crossref","first-page":"3434","DOI":"10.1038\/s41467-020-17292-4","article-title":"Marked T cell activation, senescence, exhaustion and skewing\u00a0towards TH17 in patients with COVID-19 pneumonia","volume":"11","author":"De Biasi","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.jid.2022.12.023_bib8","first-page":"599","article-title":"Italian guidelines in pemphigus - adapted from the European Dermatology Forum (EDF) and European Academy of Dermatology and Venerology (EADV)","volume":"153","author":"Feliciani","year":"2018","journal-title":"G\u00a0Ital Dermatol Venereol"},{"key":"10.1016\/j.jid.2022.12.023_bib9","doi-asserted-by":"crossref","first-page":"e13","DOI":"10.1016\/S2665-9913(21)00351-9","article-title":"Cellular and humoral immunity after the third dose of SARS-CoV-2 vaccine in patients treated with rituximab","volume":"4","author":"Felten","year":"2022","journal-title":"Lancet Rheumatol"},{"key":"10.1016\/j.jid.2022.12.023_bib10","doi-asserted-by":"crossref","first-page":"827889","DOI":"10.3389\/fimmu.2022.827889","article-title":"Pregnant women develop a specific immunological long-lived memory against SARS-CoV-2","volume":"13","author":"Fenizia","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.jid.2022.12.023_bib11","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1146\/annurev.immunol.22.012703.104702","article-title":"Central memory and effector memory T cell subsets: function, generation, and maintenance","volume":"22","author":"Sallusto","year":"2004","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.jid.2022.12.023_bib12","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.cell.2020.08.017","article-title":"Robust T\u00a0cell immunity in convalescent individuals with asymptomatic or mild COVID-19","volume":"183","author":"Sekine","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.jid.2022.12.023_bib13","doi-asserted-by":"crossref","first-page":"136","DOI":"10.3389\/fimmu.2018.00136","article-title":"Pemphigus\u2014a disease of\u00a0desmosome dysfunction caused by multiple\u00a0mechanisms","volume":"9","author":"Spindler","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.jid.2022.12.023_bib14","doi-asserted-by":"crossref","first-page":"296","DOI":"10.3389\/fmed.2018.00296","article-title":"Diagnosis of autoimmune blistering diseases","volume":"5","author":"Witte","year":"2018","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.jid.2022.12.023_bib15","article-title":"Immunotherapy for pemphigus: present and future","volume":"9","author":"Yuan","year":"2022","journal-title":"Front Med (Lausanne)"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X23000295?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X23000295?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T17:33:41Z","timestamp":1758303221000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X23000295"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":15,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["S0022202X23000295"],"URL":"https:\/\/doi.org\/10.1016\/j.jid.2022.12.023","relation":{},"ISSN":["0022-202X"],"issn-type":[{"type":"print","value":"0022-202X"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"SARS-CoV-2 Vaccination Effectiveness in Rituximab-Treated Patients Affected by Pemphigus Vulgaris","name":"articletitle","label":"Article Title"},{"value":"Journal of Investigative Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jid.2022.12.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier, Inc. on behalf of the Society for Investigative Dermatology.","name":"copyright","label":"Copyright"}]}}